WebMagneto is developing innovative thrombectomy solutions, focusing on the treatment of Pulmonary Embolism (PE). The eTrieve™ enables faster clot retrieval, using a smaller profile and presumably associated with fewer complications, compared with the competition. Magneto has a strong management team with extensive experience in medical device Web2 jul. 2024 · Treatment. Official Title: Evaluation of the Safety and Performance of Magneto PE Kit for Endovascular Thrombectomy in Patients With Acute Pulmonary Embolism. Anticipated Study Start Date : Jul 1, 2024. Anticipated Primary Completion Date : Jan 1, 2024. Anticipated Study Completion Date : Feb 1, 2024.
Jay Sanchez on LinkedIn: Is Magneto the Hero We Need to …
Web11 mei 2024 · At the ongoing Biomed Israel 2024 event, Magneto Thrombectomy Solutions Ltd. has shared successful first-in-human (FIH) results showing safety and … Web10 mei 2024 · Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the treatment of ischemic stroke and … crosswaywilmington.org
MAGNETO THROMBECTOMY SOLUTIONS LTD - GoodIP
WebMAGNETO THROMBECTOMY SOLUTIONS LTD has a total of 16 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual … WebWe proudly stand by our portfolio companies; BrainQ Technologies , Cardiovalve, CORDIO Medical Ltd., Restore Medical and Magneto Thrombectomy Solutions who are paving the way in this field and ... Web12 mei 2024 · Magneto Thrombectomy Solutions Reports Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE) On May 10, 2024, Magneto Thrombectomy Solutions focused on developing innovative thrombectomy solutions for the treatment of ischemic stroke and pulmonary embolism, presented successful first-in … crossway technologies